- CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., focuses on benefits of new wine; it has attributed sales gains to hemp oil and alcoholic beverages
- Life longevity is key issue in its marketing strategy; rice wine is a diet staple in town of Bama, China, which has one of the highest ratios in the world of centenarians-to-general population
- Warren Wang, CEO of CIIX, noted in a news release that the company had significant growth in its latest fiscal year, largely due to surging hemp oil and alcoholic beverage product sales
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotechnology Co. Ltd., a wholly owned foreign enterprise, plans to market its private brand CBD hemp-infused rice wine in December, focusing on ‘hemp enthusiasts’ and the benefits of the product. Rice wine may be one important factor in the extreme longevity realized in the Chinese town of Bama in Guangxi Province. It is known as the ‘longevity town of China’ and boasts one of the highest ratios of centenarians globally: 73 out of a population of just over 300,000 (http://cnw.fm/Vrb4p).
Summer Yun, CEO of CBD Biotech, noted in a recent news release that the company recorded its highest single-day sales of alcoholic beverage products during the 10-day period from September 1-11, 2018. Yun anticipates that the addition of CBD Hemp Wine, scheduled to debut in December 2018, will drive sustained improvement to existing sales performance.
Commenting on company revenue gains in hemp oil and alcoholic beverages, Wang of CIIX said, “Given the trends and the current demands we are seeing in the marketplace, we believe this is a significant opportunity. Moving forward, CBD Biotech plans to explore a variety of hemp products, in addition to its skin-care and alcoholic beverage products.”
The announcement comes after CIIX had reported a 41 percent jump in its sales for FY2018 ended May 31, 2018, as compared to the prior year. CIIX previously detailed plans to spin off its CBD division in the future, including CBD Biotech, Hemp Logic, Inc. and ChineseHempOil.com, Inc. (http://cnw.fm/pxD0f).
CIIX has an international Chinese-speaking audience and generates core revenue from subscriptions and consulting. Its online site, NewCoins168.com, indicates that CIIX expects to issue its own ICO in the second half of 2018 or in 2019 as part of an initiative to create a virtual investment ‘ecosystem’ for its Chinese viewers (http://cnw.fm/Ut8IK).
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
